Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.

Related Articles

Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.

J Mol Med (Berl). 2017 Nov 17;:

Authors: Brooks JF, Davies JM, Wells JW, Steptoe RJ

Abstract
Respiratory allergies represent a significant disease burden worldwide affecting up to 300 million people globally. Medication and avoidance of known triggers do not address the underlying pathology. Traditional immunotherapies for allergy aim to reinstate immune homeostasis but require years of treatment and have poor long-term efficacy. Novel approaches, such as gene-engineered hematopoietic stem cell transplantation, induce profound antigen-specific tolerance in autoimmunity. Recent evidence shows this approach may also have therapeutic utility for allergy. Here, we review the mechanisms of antigen-specific tolerance and the potential of stem cell-mediated gene therapy to induce tolerance in allergic respiratory diseases.

PMID: 29150718 [PubMed - as supplied by publisher]

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2hLCmdo
via IFTTT